Cited by 38Metabolism, Diabetes, and CancerGlycogen Storage Diseases and MyoclonusPI3K/AKT/mTOR signaling in cancer

The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes

Open access
Aiston, S., Hampson, L. J., Arden, C., Iynedjian, P. B., Agius, L.·2006·Diabetologia

Abstract

Aims/hypothesis An insulin signalling pathway leading from activation of protein kinase B (PKB, also known as Akt) to phosphorylation (inactivation) of glycogen synthase kinase-3 (GSK-3) and activation of glycogen synthase is well characterised. However, in hepatocytes, inactivation of GSK-3 is not the main mechanism by which insulin stimulates glycogen synthesis. We therefore tested whether activation of PKB causes inactivation of glycogen phosphorylase.Materials and methods We used a conditionally active form of PKB, produced using recombinant adenovirus, to test the role of acute PKB activation in the control of glycogen phosphorylase and glycogen synthesis in hepatocytes.Results Conditional activation of PKB mimicked the inactivation of phosphorylase, the activation of glycogen synthase, and the stimulation of glycogen synthesis caused by insulin. In contrast, inhibition of GSK-3 caused activation of glycogen synthase but did not mimic the stimulation of glycogen synthesis by insulin. PKB activation and GSK-3 inhibition had additive effects on the activation of glycogen synthase, indicating convergent mechanisms downstream of PKB involving inactivation of either phosphorylase or GSK-3. Glycogen synthesis correlated inversely with the activity of phosphorylase-a, irrespective of whether this was modulated by insulin, by PKB activation or by a selective phosphorylase ligand, supporting an essential role for phosphorylase inactivation in the glycogenic action of insulin in hepatocytes.Conclusions/interpretation In hepatocytes, the acute activation of PKB, but not the inhibition of GSK-3, mimics the stimulation of glycogen synthesis by insulin. This is explained by a pathway downstream of PKB leading to inactivation of phosphorylase, activation of glycogen synthase, and stimulation of glycogen synthesis, independent of the GSK-3 pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-005-0068-4

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insulin promotes glycogenesis, lipogenesis and the incorporation of amino acids into proteins.

    “Furthermore, insulin promotes glycogenesis,14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 lipogenesis27, 28 and the incorporation of amino acids into proteins;29”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [16]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 38

Authors
Aiston, S., Hampson, L. J., Arden, C., Iynedjian, P. B., & Agius, L.
Affiliations
  • AstraZeneca (United Kingdom) (GB)
  • Newcastle University (GB)
  • University of Geneva (CH)
Corresponding author
Agius, L.
Venue
Diabetologia
Published
2005-12-10
Volume
49
Issue
1
Pages
174-182
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2144269601
Cited by
38
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2013: 1 · 2012: 1
FWCI
1.12
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Diabetes UK
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
Akt/protein kinase B, insulin signaling, glycogen phosphorylase, glycogen synthase, glycogen synthase kinase-3, glycogen synthesis, hepatocytes, phosphorylase a
MeSH terms
Animals, Cells, Cultured, Enzyme Activation, Insulin, Male, Phosphorylation, Rats, Wistar, Phosphatidylinositol 3-Kinases, Hepatocytes, Glycogen Synthase Kinase 3, Proto-Oncogene Proteins c-akt, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review